Evolving Strategies for Insulin Delivery and Therapy
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 64 (11) , 1149-1161
Abstract
It has now been conclusively proven that adequate control of blood glucose delays or prevents the progression of diabetic complications. In order to achieve the suggested targets for glycaemic control necessary to reduce the incidence of diabetic complications, it has been established that a more intensive insulin regimen requiring multiple insulin injections is required for patients with type 1 diabetes mellitus. For patients with type 2 diabetes, oral antidiabetic therapy is generally used initially, but given the natural history of type 2 diabetes and the need to achieve improved glycaemic control, earlier use of insulin has been promoted. However, the use of insulin in more intensive regimens for the patient with type 1 diabetes or for earlier treatment of the patient with type 2 diabetes is not routine. Many factors are responsible for this observation. Nevertheless, available device options such as insulin pens or insulin pumps are routinely available for implementation of intensive insulin therapy. However, a major limitation for advancing to intensive insulin therapy is that the only viable way to administer insulin is through injection. Delivery options that use dermal, nasal and oral approaches have been explored. The oral approach may include gastrointestinal, buccal or pulmonary uptake. Recent evidence shows that delivery of insulin via the oral cavity with uptake occurring in the pulmonary alveoli may be the most viable clinical option in the future.Keywords
This publication has 61 references indexed in Scilit:
- Novel insulins and strict glycemic controlPostgraduate Medicine, 2003
- Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patientsDiabetic Medicine, 2003
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJournal of Clinical Investigation, 1999
- Insulin delivery using pen devicesPostgraduate Medicine, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Time to Peak Insulin Level, Relative Bioavailability, and Effect of Site of Deposition of Nebulized Insulin in Patients with Noninsulin-Dependent Diabetes MellitusJournal of Aerosol Medicine, 1998
- Pharmacokinetic Considerations of New Insulin Formulations and Routes of AdministrationClinical Pharmacokinetics, 1997
- NIDDM Patients' Fears and Hopes About Insulin Therapy: The basis of patient reluctanceDiabetes Care, 1997
- Prandial Glycaemia After a Carbohydrate-rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human InsulinDiabetic Medicine, 1996
- Parenteral absorption of insulin from the lung in diabetic childrenJournal of Paediatrics and Child Health, 1987